Fonarow GC - Search Results

1

Hyponatremia in acute heart failure syndromes: a potential therapeutic target.

Brandimarte F, Fedele F, De Luca L, Fonarow GC, Gheorghiade M. Brandimarte F, et al. Among authors: fonarow gc. Curr Heart Fail Rep. 2007 Dec;4(4):207-13. doi: 10.1007/s11897-007-0014-5. Curr Heart Fail Rep. 2007. PMID: 18221617 Review.

2

Target heart failure populations for newer therapies.

Stevenson LW, Couper G, Natterson B, Fonarow G, Hamilton MA, Woo M, Creaser JW. Stevenson LW, et al. Circulation. 1995 Nov 1;92(9 Suppl):II174-81. doi: 10.1161/01.cir.92.9.174. Circulation. 1995. PMID: 7586404

3

Prevention of heart failure.

Horwich TB, Fonarow GC. Horwich TB, et al. Among authors: fonarow gc. Curr Cardiol Rep. 2002 May;4(3):194-9. doi: 10.1007/s11886-002-0050-4. Curr Cardiol Rep. 2002. PMID: 11960587 Review.

4

Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients.

Middlekauff HR, Hui K, Yu JL, Hamilton MA, Fonarow GC, Moriguchi J, Maclellan WR, Hage A. Middlekauff HR, et al. Among authors: fonarow gc. J Card Fail. 2002 Dec;8(6):399-406. doi: 10.1054/jcaf.2002.129656. J Card Fail. 2002. PMID: 12528093 Clinical Trial.

5

The impact of obesity on survival in patients with heart failure.

Horwich TB, Fonarow GC. Horwich TB, et al. Among authors: fonarow gc. Heart Fail Monit. 2002;3(1):8-14. Heart Fail Monit. 2002. PMID: 12634883 Review.

6

B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.

Fonarow GC. Fonarow GC. Heart Fail Rev. 2003 Oct;8(4):321-5. doi: 10.1023/a:1026170228469. Heart Fail Rev. 2003. PMID: 14574051 Review.

7

Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.

Fonarow GC, Abraham WT, Cannon CP, Gheorghiade M, Sackner-Bernstein JD, Udelson JE; Post-Myocardial Infarction Guideline Committee. Fonarow GC, et al. Rev Cardiovasc Med. 2003;4 Suppl 3:S54-9. Rev Cardiovasc Med. 2003. PMID: 14584479 Review. No abstract available.

8

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J. Fonarow GC, et al. Am Heart J. 2004 Jul;148(1):43-51. doi: 10.1016/j.ahj.2004.03.004. Am Heart J. 2004. PMID: 15215791

9

Decompensated heart failure: is there a role for the outpatient use of nesiritide?

Yancy CW, Burnett JC Jr, Fonarow GC, Silver MA. Yancy CW, et al. Among authors: fonarow gc. Congest Heart Fail. 2004 Sep-Oct;10(5):230-6. doi: 10.1111/j.1527-5299.2004.03910.x. Congest Heart Fail. 2004. PMID: 15470300 Free article. Review.

10

Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.

Fonarow GC, Gheorghiade M, Abraham WT. Fonarow GC, et al. Am J Cardiol. 2004 Nov 1;94(9):1155-60. doi: 10.1016/j.amjcard.2004.07.083. Am J Cardiol. 2004. PMID: 15518610 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,768 results

Search Page

Filters